$53.2 Million is the total value of SVB FINANCIAL GROUP's 21 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
COIN | COINBASE GLOBAL INC | $30,555,533 | +4.9% | 406,973 | 0.0% | 57.48% | +4.4% | |
ROOT INCcl a | $7,446,444 | +6.4% | 783,012 | 0.0% | 14.01% | +5.9% | ||
AXSM | AXSOME THERAPEUTICS INC | $2,365,707 | -2.7% | 33,849 | 0.0% | 4.45% | -3.2% | |
STRUCTURE THERAPEUTICS INCsponsored ads | $1,782,498 | +21.3% | 35,353 | 0.0% | 3.35% | +20.7% | ||
ORCHESTRA BIOMED HOLDINGS INC | $1,108,033 | +24.6% | 127,068 | 0.0% | 2.08% | +24.0% | ||
MOONLAKE IMMUNOTHE RAPEUTICSclas s a ord | $921,861 | +11.8% | 16,173 | 0.0% | 1.73% | +11.2% | ||
ROVER GROUP INC | $660,643 | +27.5% | 105,534 | 0.0% | 1.24% | +27.0% | ||
CMAX | CAREMAX INC | $636,000 | -31.8% | 300,000 | 0.0% | 1.20% | -32.2% | |
PLANET LABS PBC | $447,452 | -19.3% | 172,097 | 0.0% | 0.84% | -19.6% | ||
GLBE | GLOBAL E ONLINE LTD | $203,230 | -2.9% | 5,114 | 0.0% | 0.38% | -3.5% | |
CGEM | CULLINAN ONCOLOGY INC | $122,320 | -15.9% | 13,516 | 0.0% | 0.23% | -16.4% | |
CARIBOU BIOSCIENCES INC | $99,013 | +12.5% | 20,714 | 0.0% | 0.19% | +12.0% | ||
PACB | PACIFIC BIOSCIENCES CALIF IN | $85,579 | -37.2% | 10,249 | 0.0% | 0.16% | -37.6% | |
MOVELLA HOLDINGS INC | $29,780 | -74.8% | 55,528 | 0.0% | 0.06% | -75.0% | ||
VERO | VENUS CONCEPT INC | $20,907 | -8.0% | 10,667 | 0.0% | 0.04% | -9.3% | |
MOLEKULE GROUP INC | $3,081 | -93.8% | 21,247 | 0.0% | 0.01% | -93.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
COINBASE GLOBAL INC | 4 | Q3 2023 | 57.5% |
OKTA INC | 4 | Q3 2023 | 20.9% |
ROOT INC | 4 | Q3 2023 | 14.0% |
AXSOME THERAPEUTICS INC | 4 | Q3 2023 | 7.1% |
CAREMAX INC | 4 | Q3 2023 | 3.0% |
PLANET LABS PBC | 4 | Q3 2023 | 2.0% |
MOONLAKE IMMUNOTHERAPEUTICS | 4 | Q3 2023 | 1.7% |
ROVER GROUP INC | 4 | Q3 2023 | 1.2% |
CULLINAN ONCOLOGY INC | 4 | Q3 2023 | 0.8% |
CARIBOU BIOSCIENCES INC | 4 | Q3 2023 | 0.8% |
View SVB FINANCIAL GROUP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ACHIEVE LIFE SCIENCES, INC. | February 10, 2023 | 1,716,764 | 8.8% |
Root, Inc. | February 10, 2023 | 783,012 | 8.6% |
BigCommerce Holdings, Inc. | February 12, 2021 | 392,224 | 0.6% |
ISC8 INC. /DE | February 17, 2015 | 34,533,213 | 11.9% |
View SVB FINANCIAL GROUP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
8-K | 2024-05-07 |
8-K | 2024-05-07 |
8-K | 2024-03-22 |
8-K | 2024-03-20 |
8-K | 2024-02-26 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
8-K | 2024-02-09 |
8-K | 2024-02-01 |
8-K | 2024-01-29 |
View SVB FINANCIAL GROUP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.